Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 19, 2026

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

PRRT as neoadjuvant treatment in NET.

Anna Sowa-Staszczak1, Alicja Hubalewska-Dydejczyk, Monika Tomaszuk

  • 1Department of Endocrinology, Jagiellonian University Medical College, Krakow, Poland. sowiana@gmail.com

Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|August 25, 2012
PubMed
Summary

Peptide receptor radionuclide therapy (PRRT) shows potential as a neoadjuvant treatment for neuroendocrine tumors (NETs). This approach may shrink tumors, enabling surgical removal and improving patient survival rates.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Controversies in NEN: An ENETS position statement on the interchangeability of somatostatin receptor PET tracers.

Journal of neuroendocrinology·2026
Same author

Vitamin D concentration is associated with enhanced neutrophil extracellular traps formation in type 2 diabetes: the effect of glycemic control.

Polish archives of internal medicine·2026
Same author

First report of enchondroma mimicking thyroid cancer metastasis on post-therapeutic 131I scintigraphy and single photon emission computed tomography / computed tomography.

Polish archives of internal medicine·2026
Same author

Ultra-late pulmonary carcinoid recurrence: challenges in long-term surveillance.

Polish archives of internal medicine·2026
Same author

Composite Pheochromocytomas: More Common Than Expected and Associated With Distinct Clinical Profile.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2026
Same author

A rare case of craniopharyngioma in the pituitary stalk region mimicking lymphocytic hypophysitis.

Polish archives of internal medicine·2026

Area of Science:

  • Oncology
  • Nuclear Medicine

Background:

  • Peptide receptor radionuclide therapy (PRRT) is primarily palliative.
  • Neuroendocrine tumors (NETs) present challenges for complete surgical resection.

Purpose of the Study:

  • To explore the neoadjuvant potential of PRRT in managing NETs.
  • To review recent evidence on PRRT for tumor size reduction prior to surgery.

Main Methods:

  • Review of recently published manuscripts on PRRT for NETs.
  • Analysis of outcomes in patients treated with somatostatin analogs labeled with beta emitters.

Main Results:

  • PRRT demonstrated tumor size reduction in a subset of NET patients.
  • Successful surgical intervention (partial or total excision) was achieved post-PRRT, including liver metastases.

More Related Videos

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

Radiation Planning Assistant - A Web-based Tool to Support High-quality Radiotherapy in Clinics with Limited Resources
05:18

Radiation Planning Assistant - A Web-based Tool to Support High-quality Radiotherapy in Clinics with Limited Resources

Published on: October 6, 2023

Related Experiment Videos

Last Updated: May 19, 2026

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

Radiation Planning Assistant - A Web-based Tool to Support High-quality Radiotherapy in Clinics with Limited Resources
05:18

Radiation Planning Assistant - A Web-based Tool to Support High-quality Radiotherapy in Clinics with Limited Resources

Published on: October 6, 2023

  • Tumor reduction correlated with prolonged overall survival.

    • Conclusions:

    • PRRT may serve as an effective neoadjuvant therapy for NETs.
    • This approach can facilitate tumor resection and improve survival.
    • Treatment protocols vary regarding isotopes, activity, and combination therapies.